Tvardi Therapeutics Inc (TVRD)
$0.79 -8.13% Close Oct 30, 2026 Live
Tvardi Therapeutics stock today
Tvardi Therapeutics closed at $0.79 on October 30, 2026, down 8.13% on the day. Over the past year it returned -83.0% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $7.00 million.
$2.00$4.00
NovJan 2026MarMayJulSep
| Period | TVRD | S&P 500 (SPY) |
|---|---|---|
| 1 month | -36.6% | -0.9% |
| 3 months | -62.2% | +2.1% |
| Year to date | -81.6% | +11.7% |
| 1 year | -83.0% | +12.4% |
| 3 years | -98.1% | +88.5% |
| 5 years | -99.9% | +76.0% |
Key statistics
- Market value
- $7.00M
- 52-week range
- $0.79 to $5.00
- Next report
- Nov 12, 2026 (estimated)
About Tvardi Therapeutics
Tvardi Therapeutics is a biopharmaceutical company developing drugs for kidney and metabolic diseases.
Sector: Health Care
More on Tvardi Therapeutics
- Financials: revenue, earnings and segmentsRevenue -50% in the year to Dec 2023
- Returns: what $1,000 became$1,000 ten years ago is $3.23 today
No forecast, no recommendation. This page describes Tvardi Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.